Aminolevulinic acid
( DrugBank: Aminolevulinic acid / KEGG DRUG: Aminolevulinic acid hydrochloride, Aminolevulinic acid )
4 diseases
34. 神経線維腫症
臨床試験数 : 165 / 薬物数 : 189 - (DrugBank : 83) / 標的遺伝子数 : 93 - 標的パスウェイ数 : 209
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
54. 成人発症スチル病
臨床試験数 : 25 / 薬物数 : 32 - (DrugBank : 16) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 99
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
180. ATR-X症候群
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 1) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
286. 遺伝性鉄芽球性貧血
臨床試験数 : 7 / 薬物数 : 25 - (DrugBank : 10) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 64
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|